Histol Histopathol
Brentuximab VedotinDiagnosis, DifferentialHodgkin Disease
Dr. Daniel Oscar Persky, MD
NPI1285736033PAC ID4880690478
- Medicare services, 2022
- 203
- Part D claims, 2022
- 74
- Publications
- 56
- Clinical trials
- 12
- Hospital affiliations
- 1
- Practice address
- 1501 N Campbell Ave, Tucson, AZ 85724
- Practice phone
- Call (520) 626-2761
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
University of Arizona
Tucson, Arizona
Find Dr. Persky's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Daniel Oscar Persky is a hematologist and oncologist in Tucson, Arizona
Dr. Persky practices at University of Arizona in Tucson, Arizona.
Dr. Persky's NPI, 1285736033, was assigned on September 2, 2006. Dr. Persky graduated from Albert Einstein College of Medicine of Yeshiva University in 2000. Dr. Persky holds Arizona license 35857.
NPI and contact details
- NPI
- 1285736033NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4880690478
- NPI enumeration date
- September 2, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (520) 626-2761
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 52
- Medical school graduation
- 2000
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Daniel Oscar Persky practices at University of Arizona in Tucson, Arizona
Dr. Persky's primary practice is University of Arizona, at 1501 N Campbell Ave, Tucson, AZ 85724 in Pima County. The practice phone is (520) 626-2761.
- University of Arizona1501 N Campbell Ave, Tucson, AZ 85724 · Pima CountyPhone(520) 626-2761
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Daniel Oscar Persky is affiliated with 3 sites of care and 1 medical group
Dr. Persky's primary practice is University of Arizona in Tucson, Arizona. Dr. Persky is also affiliated with Banner - University Medical Center Tucson. The medical group on file is Banner Medical Group. Dmand AI also links Dr. Persky to 1 more group practice or clinic, named with a free account.
University of ArizonaPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Daniel Oscar Persky's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Persky practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| University of Arizona | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Persky practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Daniel Oscar Persky is one of 259 hematologists and oncologists in Arizona
Hematology and oncology is Dr. Persky's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Persky is licensed in Arizona.
Specialties and state licenses
- Hematology and oncology, ArizonaPrimary
Hematologists and oncologists near Dr. Persky
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Daniel Oscar Persky billed Medicare for 203 services in 2022
CMS data shows 203 Medicare services from Dr. Persky across 2 procedure codes in 2022, all of them office visits. Medicare paid $10,532 for them. Every service was in an office.
Medicare services, 2022203
Paid by Medicare$10,532
Procedure codes2
Dr. Persky's Medicare services by type, 2021 to 2022
- 2021
- 2022
- Office and hospital visits
- 2021: 6152022: 20367%
- Other services
- 2021: 252022: 0100%
Dr. Persky compared with the Arizona median for hematologists and oncologists, 2022
- Dr. Persky
- Arizona median
- Medicare services
- 203vs 2,70592% below
- Part D claims
- 74vs 40482% below
Medians across 249 hematologists and oncologists in Arizona with Dmand AI profiles that report each measure.
Dr. Persky's most billed Medicare procedure codes, 2022
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Persky?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Persky and other hematologists and oncologists in Arizona.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Daniel Oscar Persky's patients have a median age of 72
Across all payers, Dmand AI patient panel data puts Dr. Persky's median patient age at 72, with 49% women.
Dr. Persky's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women49%
- Men49%
Source: Dmand AI Patient Panel Data
Dr. Daniel Oscar Persky wrote 74 Medicare Part D claims in 2022
In 2022, Dr. Persky wrote 74 Medicare Part D claims. They cover 4 drugs, with $384,198 in total drug cost. In 2021, CMS named 250 claims across 10 drugs.
Part D claims, 202274
Drugs named by CMS4
Total drug cost$384,198
Dr. Persky's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2021 to 2022
- 2021
- 2022
- Claims for drugs CMS names
- 2021: 2502022: 7470%
Drugs named by CMS: 4 in 2022, 10 in 2021.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
How Dr. Daniel Oscar Persky takes part in Medicare
Dr. Persky accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Persky by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Daniel Oscar Persky has 56 publications on record
Dmand AI links 56 papers to Dr. Persky, published from 2011 to 2023. 2021 was the busiest year, with 8. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Rituximab and Lymphoma, Large B-Cell, Diffuse. Dr. Persky has published most often in Clin Lymphoma Myeloma Leuk. Dr. Persky's most frequent co-authors are Soham Puvvada, MD, Daruka Mahadevan, MD, PhD and Paul Michael Barr, MD.
Papers56
Years published2011 to 2023
Dr. Persky's papers by year, 2014 to 2023
Topics Dr. Persky writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Rituximab
- Lymphoma, Large B-Cell, Diffuse
- Cell Line, Tumor
- Vincristine
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lymphoma, Mantle-Cell
- Antibodies, Monoclonal, Murine-Derived
Dr. Persky's most frequent co-authors
- Soham Puvvada, MD9 shared papers
- Daruka Mahadevan, MD, PhD7 shared papers
- Paul Michael Barr, MD5 shared papers
Recent publications by Dr. Persky
Antineoplastic Combined Chemotherapy ProtocolsLymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin
BenzamidesBridged Bicyclo Compounds, HeterocyclicCost-Benefit Analysis
Antineoplastic AgentsImmunoconjugatesImmunotoxins
Cell Line, TumorGene Expression ProfilingHuman T-lymphotropic virus 1
See who Dr. Persky researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Persky works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Daniel Oscar Persky has worked on 12 clinical trials
Dmand AI links Dr. Persky to 12 clinical trials, 4 of them phase 2 studies. 8 are still active or recruiting. Conditions studied include Hodgkin Disease, Lymphoma, Large B-Cell, Diffuse and Lymphoma. National Cancer Institute (NCI) sponsors the most, 5. Open Payments lists research payments to Dr. Persky that name 2 trials.
Clinical trials with Dr. Persky by phase
- 1Phase 1: 1 trial
- 1Phase 1/2: 1 trial
- 4Phase 2: 4 trials
- 4Phase 3: 4 trials
- NonePhase 4: no trials
Conditions in Dr. Persky's trials
- Hodgkin Disease
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
Investigators on the most trials with Dr. Persky
- Brian Timothy Hess, MD5 shared trials
- Kami J. Maddocks, MD4 shared trials
- Ashraf R. Aziz, MD3 shared trials
Recent clinical trials with Dr. Persky
A Phase I/II Trial of Vorinostat (SAHA) (NSC-701852) in Combination With Rituximab-CHOP in Patients With Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) (opens in a new tab)
Active, not recruitingPhase 1/2
RituximabVorinostatCyclophosphamide
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma (opens in a new tab)
Active, not recruitingPhase 3
Hodgkin DiseaseLymphomaBrentuximab VedotinNivolumabDacarbazine
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia (opens in a new tab)
Active, not recruitingPhase 3
Leukemia, Lymphocytic, Chronic, B-CellLeukemia, B-CellIbrutinibObinutuzumabVenetoclax
Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma (opens in a new tab)
Active, not recruitingPhase 2
Hodgkin DiseaseLymphomaBrentuximab VedotinNivolumabBleomycin
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma (opens in a new tab)
Active, not recruitingPhase 2
Lymphoma, FollicularLymphoma, Non-HodgkinLenalidomideObinutuzumabUmbralisib
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Daniel Oscar Persky received $28,699 in industry payments from 2016 to 2022
CMS Open Payments shows 54 general payments to Dr. Persky from 22 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 53% of the total. Sandoz Inc. paid the most, $8,584. It also lists 6 research payments totaling $2,564 from 2016 to 2022, naming 2 clinical trials.
General payments to Dr. Persky by program year, 2016 to 2022
General payments to Dr. Persky by kind, 2016 to 2022
$28.7Kin total
- Consulting fees$15,07953%
- Honoraria$8,26329%
- Food and beverage$3,13511%
- Travel and lodging$1,9347%
- Education$2881%
Companies that paid Dr. Persky the most, 2016 to 2022
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Daniel Oscar Persky graduated from Albert Einstein College of Medicine of Yeshiva University
Dr. Persky graduated from Albert Einstein College of Medicine of Yeshiva University in 2000.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Daniel Oscar Persky's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Daniel Oscar Persky
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Daniel Oscar Persky's NPI number?
Dr. Daniel Oscar Persky's NPI number is 1285736033. It was assigned on September 2, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Daniel Oscar Persky?
Dr. Daniel Oscar Persky is a hematologist and oncologist in Tucson, Arizona. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Daniel Oscar Persky practice?
Dr. Persky practices at 1501 N Campbell Ave, Tucson, AZ 85724. Dr. Persky's primary practice is University of Arizona in Tucson, Arizona. Dmand AI also links Dr. Persky to 1 group practice or clinic.
What is Dr. Daniel Oscar Persky's office phone number?
The practice phone on file for Dr. Persky is (520) 626-2761.
What is Dr. Daniel Oscar Persky's medical license number?
Dr. Persky holds Arizona license 35857.
Which hospitals is Dr. Daniel Oscar Persky affiliated with?
Dr. Persky is affiliated with Banner - University Medical Center Tucson.
What medical group is Dr. Daniel Oscar Persky part of?
Dr. Persky is linked to Banner Medical Group.
Does Dr. Daniel Oscar Persky accept Medicare?
Yes. CMS data shows Dr. Persky billed Medicare for 203 services in 2022, and Dr. Persky accepts Medicare assignment.
What services does Dr. Daniel Oscar Persky bill to Medicare?
In 2022, Dr. Persky's most billed Medicare services were office visit, established patient (99214) and office visit, established patient (99213).
Where did Dr. Daniel Oscar Persky go to medical school?
Dr. Persky graduated from Albert Einstein College of Medicine of Yeshiva University in 2000.
Show 5 more questionsShow fewer questions
What drugs does Dr. Daniel Oscar Persky prescribe most?
In 2022 Medicare Part D data, Dr. Persky's most prescribed drugs by claims were Imbruvica, Acyclovir and Venclexta.
Has Dr. Daniel Oscar Persky received payments from drug or device companies?
CMS Open Payments shows $28,699 in general payments to Dr. Persky from 22 companies from 2016 to 2022. The largest total came from Sandoz Inc.
How long has Dr. Daniel Oscar Persky been practicing?
Dr. Persky graduated from medical school in 2000, 26 years ago.
Does Dr. Daniel Oscar Persky do research?
Dmand AI links 56 publications to Dr. Persky, published from 2011 to 2023. Dr. Persky has worked on 12 clinical trials.
Who does Dr. Daniel Oscar Persky publish with?
Dr. Persky's most frequent co-authors are Soham Puvvada, MD (9 shared papers), Daruka Mahadevan, MD, PhD (7 shared papers) and Paul Michael Barr, MD (5 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Arizona by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card